[Effects of connective tissue growth factor antisense oligonucleotides on the cultured human keloid fibroblasts in

Jian-yi Liu1, Shi-rong Li, Shu-xing Ji

  • 1The Department of Plastic and Aesthetic Surgery, the Southwest Hospital of the Third Military Medical University, Chongqing 400038, China.

Zhonghua Zheng Xing Wai Ke Za Zhi = Zhonghua Zhengxing Waike Zazhi = Chinese Journal of Plastic Surgery
|April 20, 2005
PubMed
Abstract

Insights

Connective tissue growth factor (CTGF) antisense oligonucleotides (ASODN) were tested against human keloid fibroblasts. CTGF ASODN demonstrated anti-fibrotic effects by inhibiting proliferation and collagen synthesis while increasing apoptosis.

Area of Science:

  • Dermatology
  • Cell Biology
  • Molecular Biology

Context:

  • Keloids are abnormal scars resulting from excessive extracellular matrix deposition.
  • Connective tissue growth factor (CTGF) is implicated in the pathogenesis of fibrotic conditions, including keloids.

Purpose:

  • To investigate the role of CTGF in human keloid pathogenesis.
  • To evaluate the anti-fibrotic potential of CTGF antisense oligonucleotides (ASODN) in human keloid fibroblasts (HKF).

Summary:

  • CTGF ASODN were delivered into HKF using liposomes and observed via fluorescence microscopy.
  • The study measured HKF proliferation (MIT assay), apoptosis (flow cytometry), and collagen synthesis (H3-proline incorporation).
  • Results showed CTGF ASODN significantly inhibited HKF proliferation and collagen synthesis, while concurrently increasing apoptosis (P < 0.01).

Impact:

  • CTGF ASODN exhibit potential anti-fibrotic properties against human keloids in vitro.
  • These findings suggest CTGF plays a crucial role in promoting keloid fibrosis.
  • This research may inform novel therapeutic strategies for keloid treatment.

Related Concept Videos